These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8399788)

  • 1. Analytical and clinical utility of a photometric assay for blood coagulation factor XIII.
    van Wersch JW
    Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):467-71. PubMed ID: 8399788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photometric assay for blood coagulation factor XIII.
    Fickenscher K; Aab A; Stüber W
    Thromb Haemost; 1991 May; 65(5):535-40. PubMed ID: 1871715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of factor XIII activity by a new photometric assay in plasma and platelets of healthy blood donors.
    Wagner B; Seyfert UT; Gosse M; Wenzel E; Fickenscher K; Ruhl HG
    Thromb Res; 1994 Apr; 74(2):169-74. PubMed ID: 8029818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma.
    Kárpáti L; Penke B; Katona E; Balogh I; Vámosi G; Muszbek L
    Clin Chem; 2000 Dec; 46(12):1946-55. PubMed ID: 11106327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies.
    Ballerini G; Gemmati D; Moratelli S; Morelli P; Serino ML
    Thromb Res; 1995 Jun; 78(5):451-6. PubMed ID: 7660361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor XIII in pregnant smokers and non-smokers.
    van Wersch JW; Vooijs ME; Ubachs JM
    Int J Clin Lab Res; 1997; 27(1):68-71. PubMed ID: 9144031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of a new continuous UV assay for the determination of blood coagulation factor XIII activity in human plasma.
    Heins M; Fahron U; Withold W; Rick W
    Eur J Clin Chem Clin Biochem; 1994 Jun; 32(6):479-83. PubMed ID: 7918847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis.
    Kłoczko J; Wereszczyńska U; Wojtukiewicz M; Gybryelewicz A; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):539-44. PubMed ID: 2431976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests.
    Duncan EM; Dale BJ; Lloyd JV
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):340-8. PubMed ID: 24440916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A-subunit, b-subunit and a2b2-complex of coagulation factor XIII in inflammatory bowel disease].
    Ohsone T; Kubota Y; Katsumata S; Horimukai F; Miyaoka M
    Nihon Shokakibyo Gakkai Zasshi; 1988 Jun; 85(6):1317. PubMed ID: 3225950
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factor XIII].
    Takahashi I; Fukue H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():660-2. PubMed ID: 15658417
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies concerning factor XIII; with special reference to hyperlipemia.
    Cuculanu MP; Vasile VV; Popescu TA; Opincaru A; Crîsnic I; Tapalagå D
    Thromb Diath Haemorrh; 1973 Dec; 30(3):480-93. PubMed ID: 4787669
    [No Abstract]   [Full Text] [Related]  

  • 14. Microtiter assay for measurement of factor XIII activity in plasma.
    Dempfle CE; Harenberg J; Hochreuter K; Heene DL
    J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII activity during orthotopic liver transplantation.
    Himmelreich G; Müller C; Isenberg C; Bechstein WO; Roissant R; Riess H
    Semin Thromb Hemost; 1993; 19(3):243-5. PubMed ID: 7689750
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples.
    Caron C; Meley R; Le Cam Duchez V; Aillaud MF; Lavenu-Bombled C; Dutrillaux F; Flaujac C; Ryman A; Ternisien C; Lasne D; Galinat H; Pouplard C
    Int J Lab Hematol; 2017 Jun; 39(3):279-285. PubMed ID: 28318109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates.
    Song YC; Sheng D; Taubenfeld SM; Matsueda GR
    Anal Biochem; 1994 Nov; 223(1):88-92. PubMed ID: 7695107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of factor XIII analysis in blood coagulation tests].
    Yorifuji H; Ikematsu S
    Nihon Rinsho; 1989 Dec; 48 Suppl():846-8. PubMed ID: 2622017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.